GL1X · GenesisL1 explorer

Research workbench

Leishmania major N-myristoyltransferase in complex with a thienopyrimidine inhibitor

Analyse Leishmania major N-myristoyltransferase in complex with a thienopyrimidine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CGO
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycylpeptide N-tetradecanoyltransferase
EC
2.3.1.97
UniProt
Q4Q5S8
Ligands
6KV, MYA, MG
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97)protein41132% helix, 28% strandQ4Q5S8

Ligands and binding sites

  • 6KV · 3-[methyl-[2-[methyl-(1-methylpiperidin-4-yl)amino]thieno[3,2-d]pyrimidin-4-yl]amino]propanenitrile · ligand · 2 copies · chains A
  • MYA · Tetradecanoyl-coa · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19870.780.8091MG, MYA, 6KV
2980.360.7419empty

Compared structures

  • 4CGO · Leishmania major N-myristoyltransferase in complex with a thienopyrimidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.